Replies to post #115065 on Biotech Values

[jq1234]

The game changer would still be survival benefit......not sure when they may have data to report on that as wll as the remaining 68 patients entered in the trial.

I think the first step is to see some duration of response data. That's what many people are interested in first, which is why many asked during QA session. I was eagerly waiting to see some duration of response data, but very little was presented today. Have to wait until ASCO.